rdf:type |
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0003241,
umls-concept:C0019196,
umls-concept:C0022671,
umls-concept:C0087111,
umls-concept:C0205160,
umls-concept:C0205177,
umls-concept:C0205191,
umls-concept:C0229671,
umls-concept:C0376387,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
3
|
pubmed:dateCreated |
2003-6-30
|
pubmed:abstractText |
The use of interferon-alpha (IFN-alpha) to treat viral hepatitis C (HCV) occurring in kidney transplant recipients is controversial. This study reports an HCV patient successfully treated with IFN-alpha therapy achieving sustained response, negative serum HCV-mRNA and the disappearance of HCV antibodies, without impairment of renal function.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1121-8428
|
pubmed:author |
pubmed-author:BossolaMaurizioM,
pubmed-author:CastagnetoMarcoM,
pubmed-author:FerranteAngelaA,
pubmed-author:GrilloRita LucianaRL,
pubmed-author:LucianiGiovannaG,
pubmed-author:MuscaritoliMaurizioM,
pubmed-author:NanniGiuseppeG,
pubmed-author:PanocchiaNicolaN,
pubmed-author:PiccioniEmanueleE,
pubmed-author:Rossi FanelliFilippoF,
pubmed-author:TazzaLuigiL
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
417-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12832744-Antiviral Agents,
pubmed-meshheading:12832744-Child,
pubmed-meshheading:12832744-Hepacivirus,
pubmed-meshheading:12832744-Hepatitis C, Chronic,
pubmed-meshheading:12832744-Hepatitis C Antibodies,
pubmed-meshheading:12832744-Humans,
pubmed-meshheading:12832744-Interferon-alpha,
pubmed-meshheading:12832744-Kidney Transplantation,
pubmed-meshheading:12832744-Male,
pubmed-meshheading:12832744-RNA, Messenger,
pubmed-meshheading:12832744-Transaminases,
pubmed-meshheading:12832744-Treatment Outcome
|
pubmed:articleTitle |
Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C.
|
pubmed:affiliation |
Institute of Clinical Surgery, Cattolica del S. Cuore University, Rome, Italy.
|
pubmed:publicationType |
Journal Article,
Case Reports
|